Clarentis Technologies, the manufacturer of Ultra-Lyte® equipment that produces the EPA registered
medical/hospital disinfectant Ultra-Lyte® also known as Clarentis® anolyte, received notice today that
materials used in its proprietary electrolytic cells do not contain any RoHS restricted substances.
RoHS is the EU Directive that restricts the use of certain hazardous substances in electrical and electronic products (EEE products). The current list of restricted substances is found in Annex II of the Directive and includes four heavy metals (lead, mercury, cadmium, and hexavalent chromium) and two brominated flame retardants (polybrominated biphenyls (PBB) and polybrominated diphenyl ethers (PBDE)).
The European Commission will likely add additional substances to Annex II in before the end of 2015. If new substances are added, it is not clear when the restrictions will enter into force.
RoHS mandates that EEE products must not contain more than 0.1% (except for cadmium which is limited to 0.01%) by weight of homogenous material of any of listed substances. Homogenous material means a material that cannot be mechanically disjointed into different materials.
The original RoHS Directive was adopted on January 27, 2003. However, the European Parliament and Council revised this legislation June 8, 2011. Today, this revised directive is often referred to as “RoHS II”. RoHS II is an “open scope” Directive. This means that the Directive will apply to all EEE products that are “dependent on electric current or electromagnetic fields for at least one intended function. The transition will be completed in 2019.